{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:25:45Z","timestamp":1792218345638,"version":"4.4.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1124\/dmd.107.018747","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T19:54:07Z","timestamp":1201204447000},"page":"205-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":360,"title":["Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer"],"prefix":"10.1016","volume":"36","author":[{"given":"Edward T.","family":"Morgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry B.","family":"Goralski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheline","family":"Piquette-Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Renton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham R.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhusudana R.","family":"Chaluvadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kellie A.","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Kacevska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Liddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrilyn A.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohini","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Sinal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.107.018747_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2006.03.012","article-title":"The regulation of cytochrome P450 2E1 during LPS-induced inflammation in the rat","volume":"216","author":"Abdulla","year":"2006","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.107.018747_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pharmtox.46.120604.141059","article-title":"Regulation of drug-metabolizing enzymes and transporters in inflammation","volume":"46","author":"Aitken","year":"2006","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.107.018747_bib3","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0022-3565(25)39273-6","article-title":"Depression of murine hepatic mixed function oxidase during infection with Listeria monocytogenes","volume":"243","author":"Azri","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.107.018747_bib4","doi-asserted-by":"crossref","first-page":"8341","DOI":"10.1158\/1078-0432.CCR-04-1371","article-title":"Factors affecting cytochrome P-450 3A activity in cancer patients","volume":"10","author":"Baker","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"Pt 2","key":"10.1124\/dmd.107.018747_bib5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/bj3260539","article-title":"P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain","volume":"326","author":"Beaulieu","year":"1997","journal-title":"Biochem J"},{"key":"10.1124\/dmd.107.018747_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0006-291X(02)00196-1","article-title":"Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response","volume":"293","author":"Beigneux","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.107.018747_bib7","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.ejca.2005.07.014","article-title":"Differentiation-dependent expression and mitogenic action of interleukin-6 in human colon carcinoma cells: relevance for tumour progression","volume":"41","author":"Brozek","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1124\/dmd.107.018747_bib8","doi-asserted-by":"crossref","first-page":"7492","DOI":"10.1158\/1078-0432.CCR-06-0023","article-title":"Transcriptional repression of hepatic cytochrome P450 3A4 gene in the presence of cancer","volume":"12","author":"Charles","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1124\/dmd.107.018747_bib9","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0026-895X(25)08588-8","volume":"47","author":"Chen","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.107.018747_bib10","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1124\/jpet.103.057174","article-title":"Rapid transcriptional suppression of rat cytochrome P450 genes by endotoxin treatment and its inhibition by curcumin","volume":"307","author":"Cheng","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.107.018747_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0031-6997(24)01320-6","article-title":"The blood-brain barrier in neuroinflammatory diseases","volume":"49","author":"de Vries","year":"1997","journal-title":"Pharmacol Rev"},{"key":"10.1124\/dmd.107.018747_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0026-895X(24)23065-0","article-title":"Role of nitric oxide in down-regulation of CYP2B1 protein, but not RNA, in primary cultures of rat hepatocytes","volume":"60","author":"Ferrari","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.107.018747_bib13","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/jps.10433","article-title":"Modulation of hepatic cytochrome P450 during Listeria monocytogenes infection of the brain","volume":"92","author":"Garcia Del Busto Cano","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.107.018747_bib14","first-page":"G434","article-title":"Toll-like receptor-4 regulation of hepatic Cyp3a11 metabolism in a mouse model of LPS-induced CNS inflammation","volume":"289","author":"Goralski","year":"2005","journal-title":"Am J Physiol"},{"key":"10.1124\/dmd.107.018747_bib15","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1124\/dmd.105.007427","article-title":"Brain cyclosporin A levels are determined by ontogenic regulation of mdr1a expression","volume":"34","author":"Goralski","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.018747_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.bjp.0705227","article-title":"Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin","volume":"139","author":"Goralski","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.107.018747_bib17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.taap.2003.12.022","article-title":"Brain inflammation enhances 1-methyl-4-phenylpyridinium-evoked neurotoxicity in rats","volume":"196","author":"Goralski","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.107.018747_bib18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1124\/jpet.102.039404","article-title":"Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia","volume":"303","author":"Hartmann","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.107.018747_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0162-3109(00)00271-X","article-title":"Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice","volume":"1","author":"Hartmann","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1124\/dmd.107.018747_bib20","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1124\/dmd.104.002568","article-title":"Impact of endotoxin-induced changes in P-glycoprotein expression on disposition of doxorubicin in mice","volume":"33","author":"Hartmann","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.018747_bib21","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1124\/mol.105.017954","article-title":"Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-\u03b1 and lipopolysaccharide","volume":"69","author":"Hartz","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.107.018747_bib22","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1158\/1078-0432.CCR-05-1152","article-title":"Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel","volume":"11","author":"Henningsson","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1124\/dmd.107.018747_bib23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbrc.2006.12.090","article-title":"KLF6 and HSF4 transcriptionally regulate multidrug resistance transporters during inflammation","volume":"353","author":"Ho","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.107.018747_bib24","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1096\/fj.02-0195fje","article-title":"Down-regulation of human CYP3A4 by the inflammatory signal interleukin 6: molecular mechanism and transcription factors involved","volume":"16","author":"Jover","year":"2002","journal-title":"FASEB J"},{"key":"10.1124\/dmd.107.018747_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1124\/dmd.32.1.20","article-title":"Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats","volume":"32","author":"Kalitsky-Szirtes","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.018747_bib26","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0006-2952(92)90458-U","article-title":"The suppression of hepatic cytochrome P4504A mRNA mediated by the interferon inducer polyinosinic acid \u00b7 polycytidylic acid","volume":"44","author":"Knickle","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.107.018747_bib27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1542\/peds.69.4.476","article-title":"Altered theophylline clearance during an influenza B outbreak","volume":"69","author":"Kraemer","year":"1982","journal-title":"Pediatrics"},{"key":"10.1124\/dmd.107.018747_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1096\/fj.00-0339com","article-title":"Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components","volume":"15","author":"Laflamme","year":"2001","journal-title":"FASEB J"},{"key":"10.1124\/dmd.107.018747_bib29","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1139\/y01-071","article-title":"Influence of IL-6 on MDR and MRP-mediated multidrug resistance in human hepatoma cells","volume":"79","author":"Lee","year":"2001","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1124\/dmd.107.018747_bib30","doi-asserted-by":"crossref","first-page":"7398","DOI":"10.1158\/1078-0432.CCR-05-0520","article-title":"Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients","volume":"11","author":"Lepper","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1124\/dmd.107.018747_bib31","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0090-9556(24)11822-3","article-title":"Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat","volume":"27","author":"Letrent","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.018747_bib32","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0006-2952(99)00180-X","article-title":"P-glycoprotein-mediated transport of morphine in brain capillary endothelial cells","volume":"58","author":"Letrent","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.107.018747_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1471-4159.2002.01177.x","article-title":"Increased CNS uptake and enhanced antinociception of morphine-6-glucuronide in rats after inhibition of P-glycoprotein","volume":"83","author":"L\u00f6tsch","year":"2002","journal-title":"J Neurochem"},{"key":"10.1124\/dmd.107.018747_bib34","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/01.shk.0000228797.41044.08","article-title":"Emerging paradigm: Toll-like receptor 4-sentinel for the detection of tissue damage","volume":"26","author":"Mollen","year":"2006","journal-title":"Shock"},{"key":"10.1124\/dmd.107.018747_bib35","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3109\/03602539709002246","article-title":"Regulation of cytochromes P450 during inflammation and infection","volume":"29","author":"Morgan","year":"1997","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.107.018747_bib36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0300-483X(02)00283-4","article-title":"Mechanisms of cytochrome P450 regulation by inflammatory mediators","volume":"181\u2013182","author":"Morgan","year":"2002","journal-title":"Toxicology"},{"key":"10.1124\/dmd.107.018747_bib37","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0006-2952(01)00859-0","article-title":"Role of cytokines in the lipopolysaccharide-evoked depression of cytochrome P450 in the brain and liver","volume":"62","author":"Nicholson","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.107.018747_bib38","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/0006-2952(86)90114-0","article-title":"Kupffer cell factor mediated depression of hepatic parenchymal cell cytochrome P-450","volume":"35","author":"Peterson","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.107.018747_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1124\/mi.7.2.10","article-title":"Regulation of drug transporters during infection and inflammation","volume":"7","author":"Petrovic","year":"2007","journal-title":"Mol Interv"},{"key":"10.1124\/dmd.107.018747_bib40","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1023\/A:1011962818051","article-title":"Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation","volume":"15","author":"Piquette-Miller","year":"1998","journal-title":"Pharmacol Res"},{"key":"10.1124\/dmd.107.018747_bib41","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","article-title":"Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene","volume":"282","author":"Poltorak","year":"1998","journal-title":"Science"},{"key":"10.1124\/dmd.107.018747_bib42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0163-7258(01)00165-6","article-title":"Alteration of drug biotransformation and elimination during infection and inflammation","volume":"92","author":"Renton","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.107.018747_bib43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2174\/1389200043335559","article-title":"Cytochrome P450 regulation and drug biotransformation during inflammation and infection","volume":"5","author":"Renton","year":"2004","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.107.018747_bib44","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1517\/17425255.1.4.629","article-title":"Regulation of drug metabolism and disposition during inflammation and infection","volume":"1","author":"Renton","year":"2005","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.107.018747_bib45","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0006-291X(76)90713-0","article-title":"Depression of hepatic cytochrome P-450-dependent monooxygenase systems with administered interferon inducing agents","volume":"73","author":"Renton","year":"1976","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.107.018747_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0090-9556(25)06008-8","article-title":"Depression of the hepatic cytochrome P-450 monooxygenase system by administered tilorone (2,7-bis(2-(diethylamino)ethoxy)fluoren-9-one dihydrochloride)","volume":"4","author":"Renton","year":"1976","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.018747_bib47","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0022-3565(24)39102-5","article-title":"Hepatic and central nervous system cytochrome P450 are down-regulated during lipopolysaccharide-evoked localized inflammation in brain","volume":"294","author":"Renton","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.107.018747_bib48","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1124\/jpet.105.085456","article-title":"Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice","volume":"314","author":"Richardson","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.107.018747_bib49","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1124\/dmd.105.007393","article-title":"Hepatic and renal cytochrome P450 gene regulation during Citrobacter rodentium infection in wild-type and Toll-like receptor 4 mutant mice","volume":"34","author":"Richardson","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.018747_bib50","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1124\/mol.64.1.42","article-title":"Transgenic mouse models of human CYP3A4 gene regulation","volume":"64","author":"Robertson","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.107.018747_bib51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.1476","article-title":"Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplastic, and malignant human prostate","volume":"202","author":"Royuela","year":"2004","journal-title":"J Pathol"},{"issue":"Suppl 2","key":"10.1124\/dmd.107.018747_bib52","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/344939","article-title":"Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury","volume":"186","author":"Scheld","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1124\/dmd.107.018747_bib53","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1172\/JCI118214","article-title":"Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A","volume":"96","author":"Schinkel","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1124\/dmd.107.018747_bib54","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/jhep.2000.8532","article-title":"Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent","volume":"32","author":"Siewert","year":"2000","journal-title":"Hepatology"},{"key":"10.1124\/dmd.107.018747_bib55","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1139\/y84-060","article-title":"Inhibition of the synthesis of hepatic cytochrome P-450 by the interferon-inducing agent poly rI \u00b7 rCi","volume":"62","author":"Singh","year":"1984","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1124\/dmd.107.018747_bib56","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/0006-291X(82)91247-5","article-title":"Homogeneous interferon from E. coli depresses hepatic cytochrome P-450 and drug biotransformation","volume":"106","author":"Singh","year":"1982","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.107.018747_bib57","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S1470-2045(03)01034-9","article-title":"Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy","volume":"4","author":"Slaviero","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1124\/dmd.107.018747_bib58","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/mcbr.2001.0288","article-title":"Inflammation and interleukin-6 mediate reductions in the hepatic expression and transcription of the mdr1a and mdr1b Genes","volume":"4","author":"Sukhai","year":"2000","journal-title":"Mol Cell Biol Res Commun"},{"key":"10.1124\/dmd.107.018747_bib59","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jlb.60.1.8","article-title":"Endotoxin signal transduction in macrophages","volume":"60","author":"Sweet","year":"1996","journal-title":"J Leukoc Biol"},{"key":"10.1124\/dmd.107.018747_bib60","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1006\/mcbr.2000.0264","article-title":"Endotoxin downregulates hepatic expression of P-glycoprotein and MRP2 in 2-acetylaminofluorene-treated rats","volume":"4","author":"Tang","year":"2000","journal-title":"Mol Cell Biol Res Commun"},{"key":"10.1124\/dmd.107.018747_bib61","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1124\/jpet.104.076141","article-title":"The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice","volume":"312","author":"Teng","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.107.018747_bib62","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1124\/dmd.104.001487","article-title":"Enzyme-selective effects of nitric oxide on affinity and maximum velocity of various rat cytochromes P450","volume":"32","author":"Vuppugalla","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.018747_bib63","first-page":"1537","article-title":"Detection of P-glycoprotein activity in endotoxemic rats by 99mTc-sestamibi imaging","volume":"46","author":"Wang","year":"2005","journal-title":"J Nucl Med"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624015551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624015551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.107.018747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:18:51Z","timestamp":1739895531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624015551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0090955624015551"],"URL":"https:\/\/doi.org\/10.1124\/dmd.107.018747","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.107.018747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}